Impact of COVID-19 on autoimmune diseases

2022, Vol. 4, Issue 1

Impact of COVID-19 on autoimmune diseases

authors
Samah Awad AbduRahim, Zainab Mohamed Yousif, Razan Ali Aldera, Hind Fadol, Eyman Mahgoub Mustafa

abstract
Autoimmune diseases are characterized by the existence of autoantibodies and perpetuated inflammatory reactions due to the loss of immune tolerance and dysregulated immune system, leading to target organ damage and malfunction. Autoimmune diseases which are occurred as a result of COVID-19 is a new phenomenon that was attract a lot of attention globally. Autoantibodies are frequently detected in patients with COVID-19 possibly reflecting a pathogenic role of immune dysregulation. The relative role(s) played by the immune response to SARS-CoV-2 versus direct viral effects in the respiratory system and other organ systems has been questioned, with the possibility of immunopathogenesis being a major causal component of severe COVID-19. According to the evidence of COVID‐19‐mediated autoimmunity, it might be fair to think of autoimmunity as a serious complication of COVID‐19.

Download | Pages : 8-10

How to cite this article:

Samah Awad AbduRahim, Zainab Mohamed Yousif, Razan Ali Aldera, Hind Fadol, Eyman Mahgoub Mustafa. Impact of COVID-19 on autoimmune diseases. International Journal of Biotechnology and Microbiology, Volume 4, Issue 1, 2022, Pages 8-10